Skip to content

Biogen slashes Aduhelm price in half, foreshadows significant layoffs as sales continue to stagnate – Endpoints News

Biogen slashes Aduhelm price in half, foreshadows significant layoffs as sales continue to stagnate  Endpoints NewsBiogen Cuts Price for Alzheimer’s Drug Aduhelm by Half  The Wall Street JournalLive news: Biogen halves price of Alzheimer’s drug after sales fall short of expectations  Financial TimesBiogen slashes price of Aduhelm in half, plans $500M in cost-cutting  STATBiogen halves price of Alzheimer’s drug to $28200  ReutersView Full Coverage on Google News

Leave a Reply

Your email address will not be published. Required fields are marked *